Short Term Effects of Drugs: Brain, Body and Behaviour

Drug use produces measurable changes in the brain and body within minutes of the first dose. These short-term effects are not side effects in the clinical sense: they are the intended pharmacological actions of the substance on neurotransmitter systems. They explain both why drugs are used at all and why they are dangerous even in the short term. This article covers what actually happens, by drug class, in the first hours after use, including cardiovascular and respiratory effects, cognitive impairment, synthetic drug effects, mental health impact, and overdose recognition.

 

John A. Smith, medical professional and addiction counselor at Phuket Island Rehab: The short-term effects of drugs are not random. They are predictable pharmacological consequences of specific mechanisms. Cocaine blocks dopamine reuptake. Opioids bind to mu receptors in the brainstem. Alcohol enhances GABA and blocks NMDA glutamate. Each mechanism produces a specific pattern of effects that includes both the rewarding effects people seek and the dangerous effects that can kill. Understanding the mechanism is the foundation of understanding the risk.

 

How Drugs Affect the Brain: The Starting Point

 

All drugs of abuse share one common mechanism regardless of their specific pharmacology: they increase dopamine signalling in the mesolimbic reward pathway. This circuit runs from the ventral tegmental area in the midbrain to the nucleus accumbens in the forebrain. Natural rewards activate it modestly. Drugs activate it dramatically, producing dopamine surges 5 to 10 times larger than the strongest natural reward.

This outsized dopamine release produces the euphoria that makes drugs rewarding and begins the neurological changes that drive addiction with repeated use. Beyond the shared dopamine mechanism, different drug classes affect different neurotransmitter systems, which is why their short-term effects differ so substantially.

 

Short-Term Effects by Drug Class

 

Stimulants: cocaine, methamphetamine, amphetamines

 

Stimulants activate the sympathetic nervous system and flood mesolimbic reward circuits with dopamine and norepinephrine. Cocaine blocks dopamine, norepinephrine, and serotonin reuptake transporters simultaneously. Methamphetamine reverses dopamine transporter function, flooding the synapse more sustainably than cocaine.

Immediate physical effects include increased heart rate, elevated blood pressure, dilated pupils, reduced appetite, and elevated body temperature. The psychological effects include euphoria, increased energy, and a subjective sense of enhanced capability often disconnected from actual performance.

The dangerous short-term effects: cocaine addiction causes coronary artery spasm within minutes through calcium channel effects and increased sympathetic tone, restricting blood flow even in people with healthy arteries. Its sodium channel blockade can trigger fatal cardiac arrhythmias including ventricular fibrillation. Myocardial infarction in young cocaine users with no pre-existing heart disease is well-documented. Methamphetamine can produce hyperthermia exceeding 106 degrees Fahrenheit, cerebral vasoconstriction raising stroke risk, and acute paranoid psychosis even on first use in susceptible individuals.

 

Opioids: heroin, fentanyl, morphine, oxycodone

 

Opioids bind to mu-opioid receptors throughout the brain and body. In the VTA they disinhibit dopamine neurons, causing dopamine release in the nucleus accumbens. In the brainstem they bind to receptors in the pre-Botzinger complex, which regulates breathing.

Immediate effects include profound pain relief, intense euphoria, sedation, reduced anxiety, pinpoint pupils, nausea on first use, and slowed gut motility. The primary short-term danger is respiratory depression. When respiratory rate drops below 8 to 10 breaths per minute, oxygen saturation falls and death follows. Fentanyl and its analogues are 50 to 100 times more potent than morphine by weight, meaning the margin between a recreational dose and a fatal dose is extremely narrow.

Warning:  Opioid overdose signs: unconscious or unrousable, breathing below 8 per minute, pinpoint pupils, blue lips or fingernails. Administer naloxone if available, call emergency services, place in recovery position, do not leave alone.

Alcohol

 

Alcohol enhances GABA-A receptor activity (inhibitory neurotransmission) and blocks NMDA glutamate receptors (excitatory neurotransmission), producing dose-dependent CNS depression. At 0.02 to 0.05 percent BAC: relaxation, mild disinhibition. At 0.05 to 0.08: impaired judgment, reduced reaction time. At 0.08 to 0.15: slurred speech, unsteady gait, emotional lability. Above 0.15: anterograde amnesia through hippocampal NMDA disruption. Above 0.30: stupor and respiratory depression. Above 0.40: potentially fatal respiratory arrest.

Alcohol compounds respiratory depression with any other CNS depressant. Opioid-alcohol and benzodiazepine-alcohol combinations account for the majority of polysubstance overdose deaths because the synergistic GABA enhancement can completely suppress brainstem respiratory centres at doses that would be survivable for each drug alone.

 

Cannabis

 

THC binds to CB1 cannabinoid receptors in the hippocampus, prefrontal cortex, and cerebellum, modulating neurotransmitter release across multiple systems. Short-term effects include relaxation, altered time perception, increased appetite, impaired short-term memory, and slowed psychomotor coordination persisting 4 to 6 hours beyond subjective intoxication. Driving impairment in heavy users is equivalent to approximately 0.05 to 0.07 percent BAC. CB1 receptor activation in the amygdala can trigger acute anxiety and panic reactions, particularly with high-THC products.

 

Benzodiazepines

 

Benzodiazepines are positive allosteric modulators of GABA-A receptors, producing sedation, anxiolysis, anticonvulsant effects, and muscle relaxation. At higher doses or in combination with other CNS depressants, they produce respiratory depression and paradoxical disinhibition in some individuals. The primary short-term danger is the synergy with opioids: the benzodiazepine-opioid combination is the most commonly documented lethal polydrug combination in overdose mortality data.

 

MDMA (ecstasy)

 

MDMA addiction causes massive release of serotonin, dopamine, and norepinephrine and simultaneously blocks their reuptake. The serotonin flood produces feelings of emotional closeness, empathy, and heightened sensory experience. The primary short-term danger is hyperthermia: MDMA disrupts thermoregulation through serotonin system effects combined with physical activity in hot environments. Body temperatures can exceed 108 degrees Fahrenheit, triggering rhabdomyolysis and acute kidney injury. Serotonin syndrome is a risk when MDMA is combined with SSRIs, MAOIs, or tramadol.

 

Hallucinogens: LSD, psilocybin, ketamine

 

LSD and psilocybin act as 5-HT2A serotonin receptor agonists producing perceptual distortions, synesthesia, and altered time perception without significant respiratory toxicity at standard doses. The primary short-term danger is behavioural: impaired spatial navigation, distorted hazard perception, and acute panic or psychotic reactions in susceptible individuals. Ketamine is an NMDA antagonist producing dissociation and anaesthesia at higher doses, with sympathomimetic cardiovascular effects and vulnerability from the dissociated state.

 

Short-Term Effects of Synthetic Drugs

 

Synthetic drugs include synthetic cannabinoids (Spice, K2), synthetic cathinones (bath salts), novel psychoactive substances, and emerging drugs like Kpods (etomidate vape pods prevalent in Singapore and Malaysia). Their short-term effects are often less predictable than established drug classes because chemical composition varies between batches and specific dose-response data is limited.

Synthetic cannabinoids bind CB1 receptors with much higher affinity and longer duration than THC, producing severe agitation, psychosis, tachycardia, hypertension, and seizures at rates far exceeding natural cannabis. Synthetic cathinones produce extreme sympathomimetic effects with unpredictable cardiovascular toxicity. Kpods deliver etomidate, a hospital-grade anaesthetic, via inhalation, producing rapid sedation through GABA-A modulation alongside adrenal cortisol suppression that does not occur with any other recreational sedative.

The unifying risk of synthetic drugs is dose unpredictability. Emergency presentations from synthetic drug use often do not match any known toxidrome because the specific compound is unknown. Presenting emergency staff with all information about what was taken, including brand names and packaging, is essential.

For families and bystanders:  If someone is intoxicated on an unknown substance and is deteriorating, developing extreme agitation, high fever, or irregular breathing, seek emergency care immediately. Do not wait for the person to sleep it off.

 

Short-Term Effects of Substance Abuse on Mental Health

 

The short-term mental health effects of drug use operate through the same neurotransmitter systems as the physical effects but manifest as changes in mood, thought, and behaviour.

Stimulants produce subjective euphoria acutely, followed by a dysphoric crash as dopamine falls below baseline. Heavy methamphetamine use can produce acute paranoid psychosis indistinguishable from schizophrenia. Prefrontal cortex impairment from excessive dopamine stimulation explains why stimulant users consistently overestimate their own capability while exhibiting objectively impaired judgment.

Alcohol disinhibits limbic emotional responses while impairing prefrontal modulation, producing the characteristic emotional volatility of intoxication: euphoria that shifts rapidly to aggression, tearfulness, or despair. Rebound GABA downregulation and glutamate upregulation as BAC falls leaves the brain hyperexcitable, worsening anxiety in people who drink to manage it.

Opioids provide short-term relief from anxiety and emotional pain through mu-receptor effects on limbic circuits. This mechanism makes them particularly dangerous for people with underlying trauma or mood disorders: the short-term effect is relief, but the medium-term consequence is dependence in the people whose emotional regulation is most impaired by withdrawal. Cannabis at high THC concentrations produces acute anxiety and paranoid reactions through CB1 receptor activation in the amygdala. Hallucinogens can produce acute existential distress, panic, and psychotic breaks in susceptible individuals.

Clinical insight:  John A. Smith: Many people who develop drug problems started using to manage something: anxiety, pain, trauma, grief, insomnia. The drug worked in the short term, which is exactly why they kept using it. Understanding the short-term mental health effects is not just pharmacology. It is understanding why people use drugs and why stopping feels so impossible when the drug is the only thing that makes a particular emotional state bearable.

 

Cardiovascular and Respiratory Disruption

 

The cardiovascular system experiences immediate effects when drugs enter circulation. Stimulants activate the sympathetic nervous system through enhanced norepinephrine and dopamine signalling, increasing heart rate, blood pressure, and cardiac output while blocking voltage-gated sodium channels in cardiac tissue. Cocaine causes coronary artery spasm within minutes of use, restricting blood flow even in people with healthy arteries, and can trigger fatal arrhythmias including ventricular fibrillation through its sodium channel blockade.

Opioids suppress respiratory drive by binding to mu-opioid receptors in the brainstem pre-Botzinger complex. As respiratory rate falls, arterial oxygen saturation drops while carbon dioxide accumulates. Respiratory depression is the primary mechanism of opioid overdose fatality. Fentanyl can cause complete respiratory arrest within minutes of exposure at doses indistinguishable by sight from a survivable amount.

The most dangerous respiratory scenario is polydrug combinations. Alcohol with opioids, alcohol with benzodiazepines, or the triple combination of all three produce synergistic GABA enhancement that can completely suppress brainstem respiratory centres. More than 60 percent of drug-related emergency department visits involve multiple substances.

 

Polydrug Short-Term Risk: When Combinations Are More Dangerous Than Either Alone

 

Combination	Why more dangerous together	Risk level
Opioids and alcohol	Synergistic respiratory depression through GABA enhancement plus direct brainstem suppression	Extremely high: most common lethal combination
Opioids and benzodiazepines	Same synergistic mechanism; FDA black box warning exists specifically for this	Extremely high: documented in majority of overdose deaths
Cocaine and alcohol	Liver produces cocaethylene: more cardiotoxic and longer-lasting than cocaine alone; masks cardiovascular stress	High: increases cardiac risk beyond cocaine alone
MDMA and SSRIs or MAOIs	Combined serotonergic activity triggers serotonin syndrome: hyperthermia, rigidity, altered consciousness	High: can be fatal; temp above 41C is emergency
Stimulants and alcohol	Alcohol masks intoxication; users consume more of both while cardiovascular stress continues	Moderate to high
Synthetic drugs and any CNS depressant	Unpredictable potency; may suppress breathing at lower doses than expected	High: no reliable dose-response guidance available

 

 

Recognising Drug-Related Medical Emergencies

 

Drug class	Signs requiring emergency response	Key action
Opioids	Unrousable, breathing below 8 per minute, pinpoint pupils, blue lips	Naloxone if available, emergency services, recovery position
Stimulants	Chest pain, severe hypertension, temperature above 40C, extreme agitation or psychosis	Emergency services; cooling for hyperthermia; do not forcibly restrain
Alcohol	Breathing below 12 per minute, temperature below 35C, vomiting while unconscious, cannot be roused	Recovery position, emergency services; do not give food or water
MDMA	Temperature above 39C with muscle rigidity, altered consciousness	Emergency services; cooling; do not give large amounts of water (hyponatraemia risk)
Benzodiazepines and opioids	Respiratory depression, blue lips, unrousable	Naloxone for opioid component, emergency services immediately
Synthetic drugs (Kpods, bath salts, Spice)	Agitation, psychosis, extreme heart rate, seizures, collapse	Emergency services immediately; inform staff drug was synthetic

 

Warning:  The dangerous myth of sleeping it off. People do not safely sleep off severe intoxication from opioids, alcohol, or CNS depressant combinations. Respiratory depression can develop or worsen after the person appears to have fallen asleep. If someone is unconscious or cannot be roused after drug use, call emergency services immediately.

 

When Short-Term Use Has Become a Pattern

 

The short-term effects of drugs are the foundation on which dependence builds. Tolerance to the rewarding effects develops with repeated exposure: the brain downregulates dopamine receptors in response to repeated supraphysiological stimulation. The same dose produces progressively less reward over time. Meanwhile, the dangerous short-term effects do not diminish with tolerance at the same rate, so the gap between the reinforcing dose and the dangerous dose narrows.

The transition from short-term use to problematic use is a predictable neurological consequence of repeated exposure in a brain that adapts to whatever it encounters repeatedly. Understanding the short-term mechanisms explains why the transition happens and points toward what treatment addresses: the neuroadaptive changes that make stopping feel both physically and psychologically impossible without support.

For more on how repeated drug use changes the brain and what treatment involves, see our medication-assisted treatment article and alcohol use disorder treatment page.

Support:  If drug or alcohol use has become more than occasional, find addiction treatment at Phuket Island Rehab. In the US call or text 988. Text HOME to 741741 on the Crisis Text Line. International support at befrienders.org.

 

 

 

Summary

 

Short-term drug effects are the direct pharmacological consequences of specific drug-receptor interactions. Stimulants activate the sympathetic nervous system and flood mesolimbic reward circuits with dopamine, producing euphoria alongside cardiovascular stress and hyperthermia. Opioids bind to mu receptors in reward circuits and brainstem respiratory centres, producing profound euphoria alongside dose-dependent respiratory depression that is the mechanism of virtually all opioid overdose deaths. Alcohol enhances GABA and blocks NMDA glutamate in dose-dependent CNS depression that impairs cognition, coordination, and at high doses, breathing. Synthetic drugs produce short-term effects that are less predictable than established drug classes because their pharmacology varies between batches.

Polydrug combinations are the most dangerous short-term context, particularly opioids with alcohol or benzodiazepines where synergistic respiratory depression can be fatal at doses survivable for each drug alone. Short-term mental health effects include disinhibition, emotional dysregulation, acute anxiety and paranoia, and in heavy stimulant use, acute psychosis. Recognising drug-class-specific toxidromes allows appropriate emergency response. The short-term effects of drugs are also the foundation of dependence: the mechanisms that produce the reward are the mechanisms that drive the transition to problematic use.

 

As John A. Smith of Phuket Island Rehab puts it: Understanding short-term drug effects is fundamental to recognising when recreational use becomes a medical emergency. The same substances that initially produce euphoria or relaxation can quickly overwhelm the body’s adaptive mechanisms, leading to unconsciousness, cardiac arrest, or respiratory failure. Early recognition of impairment signs and immediate medical attention can often mean the difference between recovery and tragedy.

 

 

 

Frequently Asked Questions

 

What are the short-term effects of drugs on the brain?

 

All drugs of abuse increase dopamine in the mesolimbic reward pathway through different mechanisms. Cocaine and methamphetamine block or reverse dopamine reuptake transporters. Opioids disinhibit VTA dopamine neurons. Alcohol enhances GABA and blocks NMDA glutamate. MDMA floods serotonin, dopamine, and norepinephrine synapses. Cannabis modulates multiple systems through CB1 receptor activation. Each produces short-term cognitive impairment, altered judgment, and impaired coordination alongside the rewarding effects that motivate use.

 

What are the short-term effects of synthetic drugs?

 

Synthetic cannabinoids produce short-term effects far more severe than natural cannabis including agitation, psychosis, seizures, and cardiovascular collapse, because they bind CB1 receptors with much higher affinity than THC. Synthetic cathinones produce extreme sympathomimetic effects with unpredictable cardiovascular toxicity. Kpods (etomidate vape pods) produce rapid sedation through GABA-A modulation alongside adrenal cortisol suppression unique to etomidate among recreational drugs. All synthetic drugs carry the additional risk that specific pharmacology and potency vary between batches.

 

What are the short-term effects of substance abuse on mental health?

 

Stimulants produce euphoria followed by dysphoric crashes; heavy use produces acute paranoid psychosis. Alcohol produces disinhibition and emotional volatility, with rebound anxiety as BAC falls. Opioids provide short-term relief from anxiety and emotional pain, driving use in people with underlying trauma but creating dependence in those most vulnerable to withdrawal. Cannabis at high THC concentrations produces acute anxiety and paranoid reactions. MDMA produces emotional empathy acutely followed by multi-day serotonin depletion with flat affect and low mood.

 

Why are drugs bad for you even in the short term?

 

Short-term drug use causes measurable harm even before dependence develops. Cardiovascular effects from stimulants can cause heart attack on first use. Opioid respiratory depression can be fatal on first use, particularly with fentanyl. Alcohol impairs driving and judgment at every dose above the legal limit. Polydrug combinations carry exponentially increased risk compared to single substances. The rewarding effects of drugs are produced by the same mechanisms that cause the harm: there is no pharmacological free lunch.

 

How do short-term effects differ between major drug categories?

 

Stimulants activate the sympathetic nervous system producing tachycardia, hypertension, hyperthermia, euphoria, and appetite suppression. Opioids produce profound analgesia, euphoria, sedation, and respiratory depression. Alcohol and benzodiazepines enhance GABA producing sedation, disinhibition, memory impairment, and respiratory depression. Hallucinogens produce perceptual distortions and altered consciousness through 5-HT2A agonism with minimal direct respiratory toxicity. Cannabis produces relaxation, altered time perception, and impaired memory through CB1 receptor modulation.

 

When do short-term drug effects become medical emergencies?

 

Opioid overdose: breathing below 8 per minute, unrousable, blue lips. Stimulant emergency: chest pain, temperature above 40C, severe agitation. Alcohol emergency: breathing below 12 per minute, temperature below 35C, vomiting while unconscious. MDMA emergency: temperature above 39C with muscle rigidity. Any combination of opioids with alcohol or benzodiazepines: treat as emergency immediately. For any uncertain presentation on synthetic drugs: emergency services, inform staff of synthetic drug use.